Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-05-05

Clinical Trial Update: Source of Hand Weakness After Stroke [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating the source of hand weakness after stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Stroke, Cerebrovascular Accident | Phase 2 | Status: WITHDRAWN